Enhanced paracellular and transcellular paclitaxel permeation by chitosan–vitamin E succinate–N-acetyl-l-cysteine copolymer on Caco-2 cell monolayer
Source abstract
Abstract
The aim of this study was to evaluate the underlying mechanism of enhanced oral absorption of paclitaxel (PTX)-loaded chitosan–vitamin E succinate–N-acetyl-l-cysteine (CS–VES–NAC) nanomicelles from the cellular level. In aqueous solution, CS–VES–NAC copolymer self-assembled into the polymeric nanomicelles, with the size ranging from 190 to 240 nm and the drug loading content as high as 20.5 %. Cytotoxicity results showed that the PTX-loaded nanomicelles exhibited the similar effect to PTX solution (PTX-Sol) on Caco-2 cells, but no toxicity observed for blank CS–VES–NAC nanomicelles. The cellular uptake of PTX was significantly increased by CS–VES–NAC nanomicelles, compared with that of PTX-Sol, due to the possible escapement of P-glycoprotein (P-gp) efflux pumps by endocytosis pathway. Confocal laser scanning microscope (CLSM) images also confirmed CS–VES–NAC nanomicelles could be effectively internalized by Caco-2 cells. More importantly, P app value of PTX-loaded CS–VES–NAC nanomicelles was 2.3-fold higher than that of PTX-Sol, and the efflux ratio decreased by more than 10.8-fold for the nanomicelles. As a consequence of opening of tight junctions and P-gp inhibition induced by free CS–VES–NAC copolymer, the P app value of PTX was almost increased up to 19.5-fold. All the results indicate that CS–VES–NAC copolymer hold great promises as nanocarrier for antitumor drug oral delivery by improving paracellular and transcellular permeation.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Agueros M, Ruiz-Gaton L, Vauthier C, Bouchemal K, Espuelas S, Ponchel G, Irache JM (2009) Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci 38(4):405–413. doi: 10.1016/j.ejps.2009.09.01010.1016/j.ejps.2009.09.010 ↗
2. Agueros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM (2010) Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J Control Release 145(1):2–8. doi: 10.1016/j.jconrel.2010.03.01210.1016/j.jconrel.2010.03.012 ↗
3. Akhlaghi SP, Saremi S, Ostad SN, Dinarvand R, Atyabi F (2010) Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines. Nanomedicine 6(5):689–697. doi: 10.1016/j.nano.2010.01.01110.1016/j.nano.2010.01.011 ↗
4. Benet LZ, Izumi T, Zhang Y, Silverman JA, Wacher VJ (1999) Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J Control Release 62(1–2):25–31. doi: 10.1016/S0168-3659(99)00034-610.1016/S0168-3659(99)00034-6 ↗
5. Dahmani FZ, Yang H, Zhou J, Yao J, Zhang T, Zhang Q (2012) Enhanced oral bioavailability of paclitaxel in pluronic/LHR mixed polymeric micelles: preparation, in vitro and in vivo evaluation. Eur J Pharm Sci 47(1):179–189. doi: 10.1016/j.ejps.2012.05.01510.1016/j.ejps.2012.05.015 ↗
6. Dunnhaupt S, Barthelmes J, Rahmat D, Leithner K, Thurner CC, Friedl H, Bernkop-Schnurch A (2012) S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm 9(5):1331–1341. doi: 10.1021/mp200598j10.1021/mp200598j ↗
7. Gradauer K, Vonach C, Leitinger G, Kolb D, Frohlich E, Roblegg E, Bernkop-Schnurch A, Prassl R (2012) Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Int J Nanomedicine 7:2523–2534. doi: 10.2147/ijn.s29980
8. Jain S, Kumar D, Swarnakar NK, Thanki K (2012) Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33(28):6758–6768. doi: 10.1016/j.biomaterials.2012.05.02610.1016/j.biomaterials.2012.05.026 ↗
9. Jiang L, Li X, Liu L, Zhang Q (2013) Thiolated chitosan-modified PLA–PCL–TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res Lett 8(1):66. doi: 10.1186/1556-276x-8-6610.1186/1556-276X-8-66 ↗
10. Jin X, Mo R, Ding Y, Zheng W, Zhang C (2014) Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficiency and overcoming drug resistance. Mol Pharm 11(1):145–157. doi: 10.1021/mp400340k10.1021/mp400340k ↗
11. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL (2004) Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 1(1):85–96. doi: 10.1021/mp034006h10.1021/mp034006h ↗
12. Kim S, Kim JY, Huh KM, Acharya G, Park K (2008) Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. J Control Release 132(3):222–229. doi: 10.1016/j.jconrel.2008.07.00410.1016/j.jconrel.2008.07.004 ↗
13. Koudelka S, Turanek J (2012) Liposomal paclitaxel formulations. J Control Release 163(3):322–334. doi: 10.1016/j.jconrel.2012.09.00610.1016/j.jconrel.2012.09.006 ↗
14. Laffleur F, Bernkop-Schnurch A (2012) Thiomers: promising platform for macromolecular drug delivery. Future Med Chem 4(17):2205–2216. doi: 10.4155/fmc.12.16510.4155/fmc.12.165 ↗
15. Li Y, Bi Y, Xi Y, Li L (2013) Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles. J Drug Target 21(2):188–199. doi: 10.3109/1061186x.2012.73700110.3109/1061186X.2012.737001 ↗
16. Lian H, Sun J, Yu YP, Liu YH, Cao W, Wang YJ, Sun YH, Wang SL, He ZG (2011) Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. Int J Nanomedicine 6:3323–3334. doi: 10.2147/ijn.s26305
17. Lian H, Zhang TH, Sun J, Liu XH, Ren GL, Kou LF, Zhang YX, Han XP, Ding WY, Ai XY, Wu CN, Li L, Wang YJ, Sun YH, Wang SL, He ZG (2013a) Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan–vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol Pharm 10:3447–3458. doi: 10.1021/mp400282r10.1021/mp400282r ↗
18. Lian H, Zhang TH, Sun J (2013b) A rapid and sensitive determination of paclitaxel in rat plasma by UPLC-MS/MS method: application to a pharmacokinetic study. Asian J Pharm Sci 8:199–205. doi: 10.1016/j.ajps.2013.07.02610.1016/j.ajps.2013.07.026 ↗
19. Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang S, He Z (2011) Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J Pharm 421:160–169. doi: 10.1016/j.ijpharm.2011.09.00610.1016/j.ijpharm.2011.09.006 ↗
20. Lqbal J, Sarti F, Perera G, Bernkop-Schnurch A (2011) Development and in vivo evaluation of an oral drug delivery system for paclitaxel. Biomaterials 32(1):170–175. doi: 10.1016/j.biomaterials.2010.09.03610.1016/j.biomaterials.2010.09.036 ↗
21. Mert O, Lai SK, Ensign L, Yang M, Wang YY, Wood J, Hanes J (2012) A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. J Control Release 157(3):455–460. doi: 10.1016/j.jconrel.2011.08.03210.1016/j.jconrel.2011.08.032 ↗
22. Mo R, Jin X, Li N, Ju C, Sun M, Zhang C, Ping Q (2011a) The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–4620. doi: 10.1016/j.biomaterials.2011.03.00510.1016/j.biomaterials.2011.03.005 ↗
23. Mo R, Xiao Y, Sun M, Zhang C, Ping Q (2011b) Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption. Int J Pharm 409:38–45. doi: 10.1016/j.ijpharm.2011.02.02110.1016/j.ijpharm.2011.02.021 ↗
24. Nam JP, Park SC, Kim TH, Jang JY, Chio C, Jang MK, Nah JW (2013) Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Int J Pharm 457:124–135. doi: 10.1016/j.ijpharm.2013.09.02110.1016/j.ijpharm.2013.09.021 ↗
25. Orts-Gil G, Losik M, Schlaad H, Drechsler M, Hellweg T (2008) Properties of pH-responsive mixed aggregates of polystyrene-block-poly(l-lysine) and nonionic surfactant in solution and adsorbed at a solid surface. Langmuir 24:12823–12828. doi: 10.1021/la801756210.1021/la8017562 ↗
26. Orts-Gil G, Prévost S, Łosik M, Hermes F, Schlaad H, Hellweg T (2009) Polypeptide hybrid copolymers as selective micellar nanocarriers in nonaqueous media. Colloid Polym Sci 287:1295–1304. doi: 10.1007/s00396-009-2096-y10.1007/s00396-009-2096-y ↗
27. Qiu L, Zheng C, Zhao Q (2012) Mechanisms of drug resistance reversal in Dox-resistant MCF-7 cells by pH-responsive amphiphilic polyphosphazene containing diisopropylamino side groups. Mol Pharm 9(5):1109–1117. doi: 10.1021/mp200356w10.1021/mp200356w ↗
28. Rahmat D, Muller C, Barthelmes J, Shahnaz G, Martien R, Bernkop-Schnurch A (2012) Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles. Eur J Pharm Biopharm 83:149–155. doi: 10.1016/j.ejpb.2012.10.00810.1016/j.ejpb.2012.10.008 ↗
29. Roldo M, Hornof M, Caliceti P, Bernkop-Schnurch A (2004) Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm 57(1):115–121. doi: 10.1016/S0939-6411(03)00157-710.1016/S0939-6411(03)00157-7 ↗
30. Salama NN, Eddington ND, Fasano A (2006) Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 58(1):15–28. doi: 10.1016/j.addr.2006.01.00310.1016/j.addr.2006.01.003 ↗
31. Singla AK, Garg A, Aggarwal D (2002) Paclitaxel and its formulations. Int J Pharm 235(1–2):179–192. doi: 10.1016/S0378-5173(01)00986-310.1016/S0378-5173(01)00986-3 ↗
32. Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X (2009) Paclitaxel-loaded pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 376(1–2):176–185. doi: 10.1016/j.ijpharm.2009.04.03010.1016/j.ijpharm.2009.04.030 ↗
33. Yao HJ, Ju RJ, Wang XX, Zhang Y, Li RJ, Yu Y, Zhang L, Lu WL (2011) The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 32(12):3285–3302. doi: 10.1016/j.biomaterials.2011.01.03810.1016/j.biomaterials.2011.01.038 ↗
34. Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM (2012) Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm 81(3):514–523. doi: 10.1016/j.ejpb.2012.04.00110.1016/j.ejpb.2012.04.001 ↗
35. Zambito Y, Felice F, Fabiano A, Di Stefano R, Di Colo G (2013) Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan. Carbohydr Polym 92(1):33–39. doi: 10.1016/j.carbpol.2012.09.02910.1016/j.carbpol.2012.09.029 ↗
36. Zhang Z, Huang Y, Gao F, Gao Z, Bu H, Gu W, Li Y (2011) A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: in vitro characteristics and in vivo performance. Nanomedicine (Lond) 6:1365–1379. doi: 10.2217/nnm.11.3910.2217/nnm.11.39 ↗
37. Zhao L, Feng SS (2010) Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci 99(8):3552–3560. doi: 10.1002/jps.2211310.1002/jps.22113 ↗